Free Trial

Avinger (AVGR) Stock Price, News & Analysis

+0.02 (+0.68%)
(As of 10:30 AM ET)
Today's Range
50-Day Range
52-Week Range
3,034 shs
Average Volume
38,374 shs
Market Capitalization
$5.05 million
P/E Ratio
Dividend Yield
Price Target

Avinger MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
69.5% Upside
$5.00 Price Target
Short Interest
1.74% of Float Sold Short
Dividend Strength
News Sentiment
-0.46mentions of Avinger in the last 14 days
Based on 5 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($2.08) to ($1.35) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.24 out of 5 stars

AVGR stock logo

About Avinger Stock (NASDAQ:AVGR)

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

AVGR Stock Price History

AVGR Stock News Headlines Initiates Coverage on Avinger (NASDAQ:AVGR)
Avinger (AVGR) Scheduled to Post Earnings on Wednesday
Avinger, Inc.
Shanetia S. Avinger
Avinger, Inc.: Avinger Reports Third Quarter 2023 Results
Avinger Reports Third Quarter 2023 Results
Avinger (AVGR) Reports Q3 Loss, Lags Revenue Estimates
Avinger Earnings Preview
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$7.65 million
Book Value
($2.38) per share


Free Float
Market Cap
$5.02 million
Not Optionable
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Jeffrey M. Soinski (Age 62)
    President, CEO & Director
    Comp: $616.79k
  • Mr. Nabeel P. Subainati (Age 40)
    VP of Finance, Principal Financial Officer & Accounting Officer
    Comp: $347.58k
  • Mr. Himanshu N. Patel (Age 64)
    Chief Technology Officer
    Comp: $430.08k
  • Mr. Keith Schaefer
    Chief Operating Officer
  • Mr. Philip R. Preuss (Age 46)
    Chief Marketing Officer & VP of Business Operations
  • Mr. Corey Gibbs
    Vice President of Sales
  • Dr. Jaafer Golzar FACC
    M.D., Chief Medical Officer

AVGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

What is Avinger's stock price target for 2024?

1 equities research analysts have issued 12-month price targets for Avinger's stock. Their AVGR share price targets range from $5.00 to $5.00. On average, they predict the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 69.5% from the stock's current price.
View analysts price targets for AVGR
or view top-rated stocks among Wall Street analysts.

How have AVGR shares performed in 2024?

Avinger's stock was trading at $2.71 at the start of the year. Since then, AVGR stock has increased by 8.9% and is now trading at $2.95.
View the best growth stocks for 2024 here

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our AVGR earnings forecast

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) announced its quarterly earnings results on Wednesday, March, 20th. The medical device company reported ($3.93) EPS for the quarter, missing the consensus estimate of $0.64 by $4.57. The medical device company earned $1.91 million during the quarter, compared to analysts' expectations of $2.52 million.

When did Avinger's stock split?

Avinger's stock reverse split before market open on Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

Avinger (AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AVGR) was last updated on 5/22/2024 by Staff

From Our Partners